Why the study?
Does sustained-release verapamil reduce blood pressure in patients with mild to moderate uncomplicated essential hypertension?
Does sustained-release verapamil reduce blood pressure in patients with mild to moderate uncomplicated essential hypertension?
Answers are grounded in this paper and cite their sources.
Sustained-release verapamil 240 mg once daily effectively lowers blood pressure and is well tolerated as a first-line treatment for mild to moderate essential hypertension.
The efficacy of sustained-release verapamil as a first-stage treatment for mild to moderate, uncomplicated essential hypertension was studied. Nineteen patients aged 36-70 years (mean +/- SD 55 +/- 10 years) entered the study. Treatment with 240 mg sustained-release verapamil, once daily for 8 weeks, caused systolic and diastolic blood pressures to decline significantly during the first 2 weeks and this lower level was maintained until week 8. Heart rate decreased gradually during the treatment period reaching significance at week 8. After 2 weeks maximum systolic and diastolic blood pressures during isometric exercise were significantly reduced compared with pre-treatment values; there was no difference in the percentage increase occurring pre- and post-treatment. These measures for heart rate did not change significantly. Except for a significant reduction in cardiac index after 8 weeks left ventricular function and left ventricular mass were unchanged. The 24-h urinary Na+ excretion increased significantly after 2 and 8 weeks' treatment. Plasma renin activity, serum lipid concentrations and routine blood chemistries were not affected. Side-effects were transient and did not require discontinuation of therapy. In conclusion, sustained-release verapamil is an efficacious and well tolerated first-stage drug in the treatment of essential hypertension.
No takes yet. Share an insight, caveat, or question.
Karcier et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: